Parkinson's Disease Genetics Database
- Conditions
- Parkinson's Disease
- Registration Number
- NCT00855556
- Lead Sponsor
- Northwell Health
- Brief Summary
The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD).
1. To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic markers associated with the development of PD.
2. To create a database with clinical, genetic (HLA, genome screen) and medical history information that will facilitate the search for PD susceptibility genes.
3. To provide a centralized DNA repository to allow for targeted studies of genetic factors contributing to the onset, heterogeneity and progression of PD.
4. To evaluate opportunities to extend the results of research to develop methods of risk prediction, prevention and therapy for PD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 16
- Subjects must have a diagnosis of Parkinson's Disease as determined by standard neurological criteria.
- Patients ≥18 years of age who are able to provide informed consent
- Patients ≥ 18 who are decisionally impaired for whom informed consent can be obtained by a legally authorized representative.
- Patients without a diagnosis of Parkinson's Disease.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the current protocol is for establishment of the registry only and not for particular analyses of its contents 5 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The Feinstein Institute for Medical Research
🇺🇸Manhasset, New York, United States